StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Bellerophon Therapeutics Stock Performance Shares of NASDAQ:BLPH opened at $0.05 on Tuesday. The firm has a 50 day moving average of $0.05 and a 200-day moving […]